13G Filing: Knoll Capital Management Raises Stake in Synthetic Biologics, Inc. (SYN)

Page 2 of 7 SEC Filing

Cusip
No.  
87164U102
13G Page
2 of 7 Pages

1.

NAME OF REPORTING PERSONS

Knoll Capital Management, LP

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a)     ¨

(b)     x

3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

 

4,754,557

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

4,754,557

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,754,557

10.

CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES

CERTAIN SHARES ¨

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.2%

12.

TYPE OF REPORTING PERSON

PN

Page 2 of 7

Follow Theriva Biologics Inc. (NYSEMKT:TOVX)